RIBON Trademark

Trademark Overview

On Tuesday, March 29, 2016, a trademark application was filed for RIBON with the United States Patent and Trademark Office. The USPTO has given the RIBON trademark a serial number of 86956777. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 25, 2019. This trademark is owned by Ribon Therapeutics, Inc.. The RIBON trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in the diagnosis and treatment of brain trauma, oncologic diseases, immunologic diseases, cardiovascular diseases, neurodegenerative diseases, inflammatory diseases, metabolic disorders, infectious diseases, respiratory diseases, inherited eye diseases; medical diagnostic biomarker assay to identify patients for treatment of brain trauma, oncologic diseases, immunologic diseases, cardiovascular diseases, neurodegenerative diseases, inflammatory diseases, metabolic disorders, infectious diseases, respiratory diseases, inherited eye diseases
ribon

General Information

Serial Number86956777
Word MarkRIBON
Filing DateTuesday, March 29, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 25, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 30, 2016

Trademark Statements

Goods and ServicesPharmaceutical preparations for use in the diagnosis and treatment of brain trauma, oncologic diseases, immunologic diseases, cardiovascular diseases, neurodegenerative diseases, inflammatory diseases, metabolic disorders, infectious diseases, respiratory diseases, inherited eye diseases; medical diagnostic biomarker assay to identify patients for treatment of brain trauma, oncologic diseases, immunologic diseases, cardiovascular diseases, neurodegenerative diseases, inflammatory diseases, metabolic disorders, infectious diseases, respiratory diseases, inherited eye diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 4, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameRibon Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLexington, MA 02421
Party NameRibon Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLexington, MA 02421

Trademark Events

Event DateEvent Description
Monday, November 25, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, November 25, 2019ABANDONMENT - NO USE STATEMENT FILED
Wednesday, May 1, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 30, 2019EXTENSION 5 GRANTED
Wednesday, April 24, 2019EXTENSION 5 FILED
Tuesday, April 30, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, April 24, 2019TEAS EXTENSION RECEIVED
Thursday, October 18, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 16, 2018EXTENSION 4 GRANTED
Tuesday, October 16, 2018EXTENSION 4 FILED
Tuesday, October 16, 2018TEAS EXTENSION RECEIVED
Friday, April 6, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 4, 2018EXTENSION 3 GRANTED
Wednesday, April 4, 2018EXTENSION 3 FILED
Wednesday, April 4, 2018TEAS EXTENSION RECEIVED
Wednesday, October 4, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 2, 2017EXTENSION 2 GRANTED
Monday, October 2, 2017EXTENSION 2 FILED
Monday, October 2, 2017TEAS EXTENSION RECEIVED
Wednesday, April 5, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 3, 2017EXTENSION 1 GRANTED
Monday, April 3, 2017EXTENSION 1 FILED
Monday, April 3, 2017TEAS EXTENSION RECEIVED
Tuesday, October 25, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 30, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 30, 2016PUBLISHED FOR OPPOSITION
Wednesday, August 10, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 26, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, July 26, 2016ASSIGNED TO LIE
Thursday, July 14, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, July 14, 2016EXAMINER'S AMENDMENT ENTERED
Thursday, July 14, 2016NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, July 14, 2016EXAMINERS AMENDMENT E-MAILED
Thursday, July 14, 2016EXAMINERS AMENDMENT -WRITTEN
Tuesday, July 12, 2016ASSIGNED TO EXAMINER
Monday, April 4, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, April 1, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

ribon diseases metabolic neurodegenerative disorders infectious inherited respiratory cardiovascular inflammatory treatment